GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Float Percentage Of Total Shares Outstanding

Oryzon Genomics (STU:ORN) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oryzon Genomics's float shares is 0.00 Mil. Oryzon Genomics's total shares outstanding is 63.27 Mil. Oryzon Genomics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oryzon Genomics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oryzon Genomics's Institutional Ownership is 0.63%.

Oryzon Genomics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Oryzon Genomics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/63.27
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics (STU:ORN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XMAD:BST XMAD:ATRY XMAD:PHM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB
Traded in Other Exchanges
ORYZF:USA ORY:Spain
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Website
http://www.oryzon.com
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.